Fukuzawa T, Sampei Z, Haraya K, Ruike Y, Shida Kawazoe M, Shimizu Y, et al. Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases. Sci Rep. 2017;7:1080 pubmed publisher

Lodge R, Ouellet M, Barat C, Andreani G, Kumar P, Tremblay M. HIV-1 promotes intake of Leishmania parasites by enhancing phosphatidylserine-mediated, CD91/LRP-1-dependent phagocytosis in human macrophages. PLoS ONE. 2012;7:e32761 pubmed publisher

Aguilar Ramirez P, Reis E, Florido M, Barbosa A, Farah C, Costa Carvalho B, et al. Skipping of exon 30 in C5 gene results in complete human C5 deficiency and demonstrates the importance of C5d and CUB domains for stability. Mol Immunol. 2009;46:2116-23 pubmed publisher

Barel M, Hovanessian A, Meibom K, Briand J, Dupuis M, Charbit A. A novel receptor - ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu. BMC Microbiol. 2008;8:145 pubmed publisher

Mullick A, Leon Z, Min oo G, Berghout J, Lo R, Daniels E, et al. Cardiac failure in C5-deficient A/J mice after Candida albicans infection. Infect Immun. 2006;74:4439-51 pubmed

Barton P, Warren J. Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shock. Infect Immun. 1993;61:1474-81 pubmed